Study details
Enrolling now
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
Massachusetts General Hospital
NCT IDNCT04296604ClinicalTrials.gov data as of Apr 2026
Target enrollment
600
Study length
about 12 years
Ages
18–65
Locations
1 site in MA
About this study
This trial is testing if transcranial direct current stimulation can improve executive function in people with attention deficit hyperactivity disorder, bipolar disorder, borderline personality disorder, depression, schizophrenia, substance use disorders, and traumatic brain injury. The treatment involves a device that delivers tDCS.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Transcranial Direct Current Stimulation
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Devices
therapeutic
Body systems
Psychiatry / Mental Health